Clinical Trial Update: A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant trial comparing TCbHP vs ECHP-THP in HER2-positive breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ECHP-THP
• TCbHP

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 3 | Status: WITHDRAWN